Medical Affairs

Our Medical Affairs team consists of experienced and passionate pharmaceutical professionals who are dedicated to our company’s mission of getting the right medicine to the right patient at the right time.

A team that cares

The primary focus of our Clinigen Medical Affairs team is to:

  • Be a medical/scientific partner for the healthcare community
  • Enhance patient access throughout the lifecycle of our specialist medicine portfolio by demonstrating clinical value to treating physicians and payers

We achieve this focus by providing expert medical and clinical support to a range of medical specialties, patient groups, and academic stakeholders.

Clinical Development

Clinigen is continually working to bring medical therapeutics to the patients who need them most.

Our pharmaceutical drug—Proleukin® (aldesleukin)—is the first and only interleukin-2 (IL-2) product approved for use by the United States Food and Drug Administration (FDA) as well as other major non-United States regulators. Proleukin continues to be an important treatment option for appropriate patients with metastatic melanoma (mM) and metastatic renal cell carcinoma (mRCC).

Clinigen collaborates with academic institutions, scientists, and researchers who are studying IL-2.

Interested in becoming a clinical partner?

We work with clinical partners who have the dedication and desire to explore the potential for use of therapeutics in new and exciting ways.

Please use the form on this page so we can contact you to start the conversation about a clinical partnership. Or, contact ProleukinSMARC@clinigengroup.com.

Disclaimer

A. All disclosures on your part are completely voluntary and our review of your submission neither creates nor implies a confidential, fiduciary, employment or contractual relationship. Clinigen owes NO COMPENSATION, COMMISSION, OR ANY OTHER PAYMENT to you as a result of your submission.
B. All information you are disclosing is nonconfidential and nonproprietary. Clinigen shall not be liable for any disclosure of any information you submit.
C. Clinigen shall not be obligated to specify the reasons for any decision it makes regarding the submission or to reveal any past or present activities that relate to the submission.
D. You will not challenge or object, or assist any third party to challenge or object, to any use Clinigen may make of your submission and any information contained therein for any purpose, and you expressly waive any rights you may have to do so.
E. You have read, understand, and agree to the Clinigen website Terms of Use and Privacy Policy.

I certify that I have read and understood the above, and by selecting Submit and submitting this form, I indicate my intention to be legally bound to the terms of the above Disclaimer.